Older adults with anemia had 66% higher odds of developing dementia, with those with elevated Alzheimer’s disease blood ...
Mass General Brigham researchers used long-term data and a blood test for the biomarker pTau217 to identify the earliest signs of Alzheimer’s disease in cognitively healthy adults.
Plasma pTau217 may detect initial buildup of AD-related brain changes before they can be detected by current ‘gold standard’ ...
Ann Mongan, director of translational research at BMS, outlines how biomarkers hold pivotal roles in clinical trials.
Brazilian researchers have developed an electrochemical sensor that can detect pancreatic cancer in its early stages. The ...
Determining the presence of a protein in non-tumor cells within the cancer microenvironment could be one of the keys to establishing prognosis in patients with colon and rectal cancer.
A new study suggests that a urine-based biomarker test shows promise in forecasting bladder cancer treatment response, which ...
U.S. health regulators are intensifying oversight of artificial intelligence tools while keeping a cautious stance on using biomarkers as surrogate endpoints in drug approvals. The FDA, CMS, and HHS ...
Parth Desai, MBBS, MD, discusses how clinicians balance liquid biopsy, tissue testing, and fast-start chemo to personalize ...
US regulators are maintaining a cautious stance on using biomarkers as surrogate endpoints for drug approvals, even as 2026 ICD-10 coding rules tighten documentation standards. The FDA’s recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results